Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KEEL vs GSK✓SelectedUSD · GSKKEEL vs GSK performance historyLatest closeAs of-19.59%11/20
Stock and ETF performance explorer

KEEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-41.2%
GSK return
-3.6%
Excess return
-37.7%
Maximum drawdown
-43.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-19.6%-0.1%-19.5%-19.7%
7D-26.1%-5.3%-20.7%-30.0%
30D-42.7%-3.7%-39.1%-44.5%
All-41.2%-3.6%-37.7%-43.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1mo analysis · Full analysis span regression · Available span rolling